Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6509
    -0.0009 (-0.13%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    108,077.09
    +515.84 (+0.48%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6038
    +0.0004 (+0.06%)
     
  • AUD/NZD

    1.0900
    -0.0002 (-0.02%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,452.25
    +284.18 (+0.71%)
     

MERGER INVESTIGATION: Halper Sadeh LLP Investigates CMD, COHR, PS, OXFD; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to STERIS plc for approximately $16.93 in cash and 0.33787 STERIS ordinary shares for each Cantel common share. If you are a Cantel shareholder, click here to learn more about your rights and options.

Coherent, Inc. (NASDAQ: COHR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Lumentum Holdings Inc. Under the terms of the merger agreement, Coherent shareholders will receive $100.00 per share in cash and 1.1851 shares of Lumentum common stock for each Coherent share they own. If you are a Coherent shareholder, click here to learn more about your rights and options.

Pluralsight, Inc. (NASDAQ: PS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Vista Equity Partners for $20.26 per share. If you are a Pluralsight shareholder, click here to learn more about your rights and options.

Oxford Immunotec Global PLC (NASDAQ: OXFD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to PerkinElmer, Inc. for $22.00 in cash per share. If you are an Oxford shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

ADVERTISEMENT

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com